Clarifying Authority over Nicotine Act of 2021

Bill 117 hr 6286, also known as the Clarifying Authority over Nicotine Act of 2021, aims to address the regulation of nicotine products in the United States. The bill seeks to clarify the authority of the Food and Drug Administration (FDA) over the regulation of nicotine-containing products, including e-cigarettes and other electronic nicotine delivery systems.

The bill outlines specific provisions related to the regulation of nicotine products, including requirements for manufacturers to submit product applications to the FDA for approval. It also addresses the labeling and advertising of nicotine products, as well as restrictions on the sale and distribution of these products to minors.

Additionally, the bill includes provisions related to the enforcement of regulations, including penalties for violations of the law. It also calls for increased research and data collection on the health effects of nicotine products, as well as efforts to educate the public about the risks associated with their use. Overall, the Clarifying Authority over Nicotine Act of 2021 aims to strengthen the FDA's authority to regulate nicotine products and protect public health. It addresses key issues related to the marketing, sale, and use of these products, with the goal of reducing their harmful impact on individuals, particularly young people.